Skip to main content
SpringerLink
Log in

Confirmation of the utility of the Wells’ Score for pulmonary embolism in patients with sickle cell disease

  • Letter to the Editor
  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Naik RP, Streiff MB, Haywood C, Segal JB, Lanzkron S (2014) Venous thromboembolism incidence in the cooperative study of sickle cell disease. J Thromb Haemost 12(12):2010–2016. https://doi.org/10.1111/jth.12744

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Graham JK, Mosunjac M, Hanzlick RL, Mosunjac M (2007) Sickle cell lung disease and sudden death. Am J Forensic Med & Path 28(2):168–172

    Article  Google Scholar 

  3. Raja AS, Greenberg JO, Qaseem A et al (2015) Evaluation of patients with suspected acute pulmonary embolism: Best practice advice from the clinical guidelines committee of the American college of physicians. Ann Intern Med 163:701–711

    Article  Google Scholar 

  4. Altaf S, Sakib S, Levy Y, Sadler M (2018) Abstract No 681 Predictability of D-dimer levels in detecting pulmonary embolism in the sickle cell population. J Vascu Intervent Radiol 29(4):S280. https://doi.org/10.1016/j.jvir.2018.01.726

    Article  Google Scholar 

  5. Bates DDB, Liu Z, Gibbons J, Lebedis CA, Holalkere NS (2019) Sickle cell disease and venous thromboembolism: a retrospective comparison of the rate of positive CT pulmonary angiography in the emergency department. Eur J Radiol 110:256–259. https://doi.org/10.1016/j.ejrad.2018.11.033

    Article  CAS  PubMed  Google Scholar 

  6. Dessap AM, Deux J-F, Abidi N et al (2011) Pulmonary artery thrombosis during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med 184(9):1022–1029. https://doi.org/10.1164/rccm.201105-0783oc

    Article  Google Scholar 

  7. Winchenne A, Cecchini J, Deux J-F et al (2017) A clinical risk score for pulmonary artery thrombosis during acute chest syndrome in adult patients with sickle cell disease. Br J Haematol 179(4):627–634. https://doi.org/10.1111/bjh.14914

    Article  CAS  PubMed  Google Scholar 

  8. El-Amin N, Lauzon SD, Nietert PJ, Kanter J (2021) Which adults with sickle cell disease need an evaluation for pulmonary embolism? Br J Haematol 195(3):447–455. https://doi.org/10.1111/bjh.17552

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This project was supported in part by grants from the National Institutes of Health (NCATS Grant Number UL1TR001450, NIGMS Grant Number U54GM104941, and NIAMS Grant Number P30AR072582). The contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH, NCATS, NIGMS, or NIAMS.

Author information

Authors and Affiliations

  1. Division of Hematology and Oncology, University of Alabama at Birmingham, 1720 2nd Ave South, NP 2503, Birmingham, AL, 35294, USA

    Jori E. May & Julie Kanter

  2. Eli Lilly and Company, Indianapolis, IN, USA

    Steven D. Lauzon

  3. Department of Internal Medicine, Division of Hematology, Mayo Clinic, Rochester, MN, USA

    Richard C. Godby

Authors
  1. Jori E. May
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven D. Lauzon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Richard C. Godby
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Julie Kanter
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jori E. May.

Ethics declarations

Conflict of interest

SDL is an employee and minority shareholder in Eli Lilly and Company and was employed at Medical University of South Carolina when the statistical analysis was performed. JK is provides consultant for Novartis, Graphite Bio, Fulcrum Therapeutics and Forma Therapeutics (no relevant conflict of interest in this manuscript).

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

May, J.E., Lauzon, S.D., Godby, R.C. et al. Confirmation of the utility of the Wells’ Score for pulmonary embolism in patients with sickle cell disease. J Thromb Thrombolysis 54, 193–196 (2022). https://doi.org/10.1007/s11239-022-02656-y

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-022-02656-y

Search

Navigation